Examination of the usefulness of new dosage forms for external preparation (frothiness sprays) of the heparin similar material agent
- Conditions
- dry skin
- Registration Number
- JPRN-UMIN000027664
- Lead Sponsor
- on-Profit Organization Health Institute Research of Skin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Patients who are treated for an agent for anti-inflammatory external preparation, and they visit a hospital for treatment regularly. 2) Patients with hemorrhagic blood disorder 3) Patient that it are expected that little bleeding causes a serious result. 4) Patients who use a steroid or anti-allergic drug. 5) Patients with a medical history of the serious disease. 6) Patients who have difficulty in patient diary entry. 7) A pregnant woman or the woman who may be pregnant and the woman whom I am nursing. The patient who hopes for the pregnancy during a study period. 8) The patients that the co-investigator judged this study enforcement to be inappropriate. 9) The patients who participate in other clinical trials for the past three months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method